BioCardia, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
BioCardia, Inc. (BCDA) reported Cash and Cash Equivalents, Period Increase (Decrease) of $5.60 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-10-17.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2016-10-17
- BioCardia, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-09-30 was $5.57M, a 14544.74% increase year-over-year.
- BioCardia, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-06-30 was -$53.00K, a 158.89% decline year-over-year.
- BioCardia, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2016-03-31 was $85.00K, a 4.49% decline year-over-year.
- BioCardia, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2015-12-31 was $114.00K, a 115.09% increase year-over-year.
- BioCardia, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $331.00K, a 54.67% increase from fiscal 2014.
- BioCardia, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2014 was $214.00K, a 692.59% increase from fiscal 2013.
- BioCardia, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2013 was $27.00K, a 95.42% decline from fiscal 2012.
- BioCardia, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2012 was $590.00K, a 95.30% decline from fiscal 2011.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 15 month |
|---|---|---|---|---|---|
| 2016-09-30 | $5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | $5.51M derived: sum of 2 quarters · filed 2016-10-17 | $5.60M 10-Q · filed 2016-10-17 | $5.71M derived: sum of 4 quarters · filed 2016-10-17 | |
| 2016-06-30 | -$53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $32.00K 10-Q · filed 2016-08-02 | $146.00K derived: sum of 3 quarters · filed 2016-08-02 | $184.00K derived: sum of 4 quarters · filed 2016-10-17 | |
| 2016-03-31 | $85.00K 10-Q · filed 2016-05-03 | $199.00K derived: sum of 2 quarters · filed 2016-05-03 | $237.00K derived: sum of 3 quarters · filed 2016-10-17 | $327.00K derived: sum of 4 quarters · filed 2016-10-17 | |
| 2015-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $152.00K derived: sum of 2 quarters · filed 2016-10-17 | $242.00K derived: sum of 3 quarters · filed 2016-10-17 | $331.00K 10-K · filed 2016-03-25 | |
| 2015-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | $128.00K derived: sum of 2 quarters · filed 2016-10-17 | $217.00K 10-Q · filed 2016-10-17 | $270.00K derived: sum of 4 quarters · filed 2016-10-17 | |
| 2015-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $179.00K 10-Q · filed 2016-08-02 | $232.00K derived: sum of 3 quarters · filed 2016-08-02 | $287.00K derived: sum of 4 quarters · filed 2016-08-02 | |
| 2015-03-31 | $89.00K 10-Q · filed 2016-05-03 | $142.00K derived: sum of 2 quarters · filed 2016-05-03 | $197.00K derived: sum of 3 quarters · filed 2016-05-03 | $276.00K derived: sum of 4 quarters · filed 2016-05-03 | |
| 2014-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $108.00K derived: sum of 2 quarters · filed 2016-03-25 | $187.00K derived: sum of 3 quarters · filed 2016-03-25 | $214.00K 10-K · filed 2016-03-25 | |
| 2014-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $134.00K derived: sum of 2 quarters · filed 2015-10-29 | $161.00K 10-Q · filed 2015-10-29 | $193.00K derived: sum of 4 quarters · filed 2015-10-29 | |
| 2014-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $106.00K 10-Q · filed 2015-08-12 | $138.00K derived: sum of 3 quarters · filed 2015-08-12 | $132.00K derived: sum of 4 quarters · filed 2015-08-12 | |
| 2014-03-31 | $27.00K 10-Q · filed 2015-05-12 | $59.00K derived: sum of 2 quarters · filed 2015-05-12 | $53.00K derived: sum of 3 quarters · filed 2015-05-12 | $68.00K derived: sum of 4 quarters · filed 2015-05-12 | $54.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-24 | $26.00K derived: sum of 2 quarters · filed 2015-03-24 | $41.00K derived: sum of 3 quarters · filed 2015-03-24 | $27.00K 10-K · filed 2015-03-24 | |
| 2013-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $9.00K derived: sum of 2 quarters · filed 2014-11-06 | -$5.00K 10-Q · filed 2014-11-06 | $440.00K derived: sum of 4 quarters · filed 2014-11-06 | |
| 2013-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $1.00K 10-Q · filed 2014-08-06 | $446.00K derived: sum of 3 quarters · filed 2014-08-06 | $385.00K derived: sum of 4 quarters · filed 2014-08-06 | |
| 2013-03-31 | -$14.00K 10-Q · filed 2014-05-12 | $431.00K derived: sum of 2 quarters · filed 2014-05-12 | $370.00K derived: sum of 3 quarters · filed 2014-05-12 | $602.00K derived: sum of 4 quarters · filed 2014-05-12 | |
| 2012-12-31 | $445.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | $384.00K derived: sum of 2 quarters · filed 2014-03-24 | $616.00K derived: sum of 3 quarters · filed 2014-03-24 | $590.00K 10-K · filed 2014-03-24 | |
| 2012-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $171.00K derived: sum of 2 quarters · filed 2013-11-01 | $145.00K 10-Q · filed 2013-11-01 | $215.00K derived: sum of 4 quarters · filed 2013-11-01 | |
| 2012-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | $206.00K 10-Q · filed 2013-07-26 | $276.00K derived: sum of 3 quarters · filed 2013-07-26 | $192.00K derived: sum of 4 quarters · filed 2013-07-26 | |
| 2012-03-31 | -$26.00K 10-Q · filed 2013-05-10 | $44.00K derived: sum of 2 quarters · filed 2013-05-10 | -$40.00K derived: sum of 3 quarters · filed 2013-05-10 | $12.41M derived: sum of 4 quarters · filed 2013-05-10 | |
| 2011-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | -$14.00K derived: sum of 2 quarters · filed 2013-03-22 | $12.44M derived: sum of 3 quarters · filed 2013-03-22 | $12.55M 10-K · filed 2013-03-22 | |
| 2011-09-30 | -$84.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $12.37M derived: sum of 2 quarters · filed 2012-11-08 | $12.48M 10-Q · filed 2012-11-08 | $12.41M derived: sum of 4 quarters · filed 2012-11-08 | |
| 2011-06-30 | $12.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $12.56M 10-Q · filed 2012-08-10 | $12.50M derived: sum of 3 quarters · filed 2012-08-10 | $11.03M derived: sum of 4 quarters · filed 2012-08-10 | |
| 2011-03-31 | $114.00K 10-Q · filed 2012-05-15 | $45.00K derived: sum of 2 quarters · filed 2012-05-15 | -$1.42M derived: sum of 3 quarters · filed 2012-05-15 | ||
| 2010-12-31 | -$69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$1.54M derived: sum of 2 quarters · filed 2012-03-29 | -$4.85M 10-K · filed 2012-03-29 | ||
| 2010-09-30 | -$1.47M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-15 | -$4.78M 10-Q · filed 2011-11-15 | |||
| 2010-06-30 | -$3.31M 10-Q/A · filed 2011-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |